APA (7th ed.) Citation

DE, V., N, Y., M, A., J, B., D, F., DV, G., . . . JS, A. (2011). Molecular clinical safety intelligence: A system for bridging clinically focused safety knowledge to early-stage drug discovery - the GSK experience. Drug discovery today, 16(15-16), 646. https://doi.org/10.1016/j.drudis.2011.05.001

Chicago Style (17th ed.) Citation

DE, Vanderwall, et al. "Molecular Clinical Safety Intelligence: A System for Bridging Clinically Focused Safety Knowledge to Early-stage Drug Discovery - the GSK Experience." Drug Discovery Today 16, no. 15-16 (2011): 646. https://doi.org/10.1016/j.drudis.2011.05.001.

MLA (9th ed.) Citation

DE, Vanderwall, et al. "Molecular Clinical Safety Intelligence: A System for Bridging Clinically Focused Safety Knowledge to Early-stage Drug Discovery - the GSK Experience." Drug Discovery Today, vol. 16, no. 15-16, 2011, p. 646, https://doi.org/10.1016/j.drudis.2011.05.001.